Vaxess Technologies

Vaxess Technologies

A medical company in Massachusetts focusing on lowering the cost of vaccine distribution.

Vaxess is a medical company in Massachusetts focusing on lowering the cost of vaccine distribution. Founded 2011 in Cambridge, Massachusetts, United States by Fiorenzo Omenetto, Kathryn Kosuda, Livio Valenti, Michael Schrader and Patrick Ho, Vaxess Technologies has raised a total of $19.8M in funding over 14 rounds. Their latest funding was raised on June 27, 2019 from a Series A round. The company is funded by 11 investors, with BioInnovation Capital and The Engine as the most recent investors. Vaxess is commercializing a proprietary technology that uses a silk-derived protein to stabilize vaccines so they can be stored and shipped without refrigeration and a novel sustained release microneedle for improved vaccine delivery. The company's platform uses the properties of fibroin, a protein derived from naturally-sourced silk fibers for creating vaccines which are stable even under extreme environmental conditions.

Vaxess developed a drug patch delivery system called MIMIX that removes the need for refrigerated storage and syringes and allows vaccines to be shipped to patients for self-administration. The applicator deploys a pain-free patch to the forearm that delivers a vaccine or drug into the skin after five minutes. The patch uses smart-release technology to release slowly, which triggers an immune response similar to that of an actual infection. The patch is constructed with silk-based material that protects the vaccine and keeps it stable without refrigeration. At home delivery of vaccines and therapeutics could reduce transmission of infectious diseases to healthcare workers, and could be helpful as COVID-19 vaccines and treatments become available.

Timeline

February 3, 2105
Vaxess Technologies raises a $1,000,000 venture round from Verizon Communications.
June 27, 2019
Vaxess Technologies raises a $3,600,000 series A round from Mission BioCapital and The Engine.
October 9, 2018
Vaxess Technologies raises a $650,000 grant from National Science Foundation.
December 14, 2017
Vaxess Technologies raises a $1,500,000 grant from National Institutes of Health.
February 28, 2017
Vaxess Technologies raises a $6,000,000 grant from Bill & Melinda Gates Foundation.
January 30, 2017
Vaxess Technologies raises a $862,900 venture round from BioInnovation Capital.
November 18, 2016
Vaxess Technologies raises a $750,000 grant from National Science Foundation.
April 6, 2015
Vaxess Technologies raises a $220,000 grant from National Institutes of Health.
April 5, 2015
Vaxess Technologies raises a $150,000 grant from National Science Foundation.
January 1, 2015
Vaxess Technologies raises a $225,000 grant from National Institutes of Health.
Page 1 of 2

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
Vaxess Technologies Series A round, June 2019
3,600,000
June 27, 2019
10 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Barry Bloom

Advisor

Jeffrey Erwin

Employee

Kathryn Kosuda

Founder

LabCentral

Incubator

Livio Valenti

Founder

Michael Schrader

Founder

Patrick Ho

Founder

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.